Athithan Rattanaburi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Athithan Rattanaburi has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Ingporn Jiamset
3 shared publicationsYuthasak Suphasynth
3 shared publicationsKulisara Nanthamongkolkul
2 shared publications- Anukoon Kaewborisutsakul
Neurological Surgery Unit, Department of Surgery, Faculty of Medicine Prince of Songkla University Songkhla Thailand
1 shared publication - Apiwat Aue-Aungkul
Obstetrics and Gynaecology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand
1 shared publication Aroontorn Pichatechaiyoot
Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand
1 shared publication
Latest Publications
- Open Access
- 1 April 2026
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 18, 1-11
Comparison of Surgical Outcomes Among Open, Laparoscopic, and Robotic Surgeries in Women with Obesity Diagnosed with Endometrial Cancer: Results from a Quaternary Hospital in Thailand
We compared the surgical outcomes of robotic surgery (RS), laparoscopic surgery (LS), and open surgery (OS) in Asian women with obesity diagnosed with endometrial cancer. In this retrospective cohort study, the data of 248 patients with a body mass index (BMI) of ≥25 kg/m2, who were treated between 2019 and 2024 (129 OS, 66 LS, and 53 RS), were analyzed. Clinical and surgical information was extracted from the electronic health records and compared between the OS, LS, and RS groups using the chi-square test or Fisher’s exact test for categorical variables and the Student’s t-test or Kruskal–Wallis test, as applicable, for continuous variables. Compared with the OS and LS groups, the RS group had a significantly higher median BMI and higher rates of obstructive sleep apnea, yet demonstrated superior perioperative outcomes. Sentinel lymph node dissection was performed predominantly in the RS group, whereas systemic lymphadenectomy was more commonly undertaken in the OS and LS groups. However, after adjusting for the type of lymphadenectomy, no significant effect on estimated blood loss (EBL) was observed. RS was associated with the lowest EBL, no transfusion requirements, and significantly reduced postoperative pain and opioid consumption compared with LS and OS (p < 0.001). Furthermore, RS resulted in the shortest median hospital stay (42 h) compared to LS (64 h) and OS (86 h). The overall complication rates were markedly lower in the RS group (9.4%) than in the LS (30.3%) and OS (44.2%) groups, with no high-grade complications or conversions to laparotomy observed in the robotic cases. These findings suggested that robotic surgery is a safe and highly effective approach for Asian women with obesity, offering reduced morbidity and accelerated recovery, despite higher baseline patient complexity.
- 1 April 2026
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 18, 1-11
Open AccessComparison of Surgical Outcomes Among Open, Laparoscopic, and Robotic Surgeries in Women with Obesity Diagnosed with Endometrial Cancer: Results from a Quaternary Hospital in Thailand
We compared the surgical outcomes of robotic surgery (RS), laparoscopic surgery (LS), and open surgery (OS) in Asian women with obesity diagnosed with endometrial cancer. In this retrospective cohort study, the data of 248 patients with a body mass index (BMI) of ≥25 kg/m2, who were treated between 2019 and 2024 (129 OS, 66 LS, and 53 RS), were analyzed. Clinical and surgical information was extracted from the electronic health records and compared between the OS, LS, and RS groups using the chi-square test or Fisher’s exact test for categorical variables and the Student’s t-test or Kruskal–Wallis test, as applicable, for continuous variables. Compared with the OS and LS groups, the RS group had a significantly higher median BMI and higher rates of obstructive sleep apnea, yet demonstrated superior perioperative outcomes. Sentinel lymph node dissection was performed predominantly in the RS group, whereas systemic lymphadenectomy was more commonly undertaken in the OS and LS groups. However, after adjusting for the type of lymphadenectomy, no significant effect on estimated blood loss (EBL) was observed. RS was associated with the lowest EBL, no transfusion requirements, and significantly reduced postoperative pain and opioid consumption compared with LS and OS (p < 0.001). Furthermore, RS resulted in the shortest median hospital stay (42 h) compared to LS (64 h) and OS (86 h). The overall complication rates were markedly lower in the RS group (9.4%) than in the LS (30.3%) and OS (44.2%) groups, with no high-grade complications or conversions to laparotomy observed in the robotic cases. These findings suggested that robotic surgery is a safe and highly effective approach for Asian women with obesity, offering reduced morbidity and accelerated recovery, despite higher baseline patient complexity.
- 6 January 2026
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 173 (3) , 1617-1627
Diagnostic performance of human papillomavirus DNA cycle threshold values in the detection of high‐grade cervical intraepithelial neoplasia
Objectives: Cervical cancer remains a major public health burden in low‐ and middle‐income countries, primarily caused by high‐risk human papillomavirus (hrHPV) infection. Although HPV DNA testing is highly sensitive, its low specificity necessitates effective triage strategies. Cycle threshold (CT) values from real‐time polymerase chain reaction assays reflect viral load and might serve as potential biomarkers for triage; however, their clinical significance remains unclear. Methods: This retrospective cohort study included women aged 25–65 years who tested positive for hrHPV between September 2023 and April 2025 at three Southern Thailand hospitals. All participants had CT values and underwent colposcopy with biopsy. HPV testing was performed using the Allplex HPV HR Detection assay, and diagnostic performance was evaluated using receiver operating characteristic analysis. Results: Among 677 hrHPV‐positive women, 286 met the eligibility criteria, with cervical intraepithelial neoplasia 2 or higher (CIN2+) detected in 56 (19.6%). HPV16, HPV52, and HPV58 were the most common genotypes in CIN2+ cases. CT values were significantly inversely correlated with lesion severity ( r = −0.13, P = 0.025). For non‐16/18 hrHPV infections, a CT cutoff value of <32.94 improved the area under the curve from 0.54 to 0.65, yielding a sensitivity and specificity of 89% and 41%, respectively. Conclusion: Cycle threshold values demonstrated modest discriminatory performance. Therefore, they should not be used as the sole biomarkers for triage; rather, they should be used as a supplementary tool to aid in clinical decision‐making. Further validation in larger prospective studies is warranted.
- 6 January 2026
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 173 (3) , 1617-1627
Diagnostic performance of human papillomavirus DNA cycle threshold values in the detection of high‐grade cervical intraepithelial neoplasia
Objectives: Cervical cancer remains a major public health burden in low‐ and middle‐income countries, primarily caused by high‐risk human papillomavirus (hrHPV) infection. Although HPV DNA testing is highly sensitive, its low specificity necessitates effective triage strategies. Cycle threshold (CT) values from real‐time polymerase chain reaction assays reflect viral load and might serve as potential biomarkers for triage; however, their clinical significance remains unclear. Methods: This retrospective cohort study included women aged 25–65 years who tested positive for hrHPV between September 2023 and April 2025 at three Southern Thailand hospitals. All participants had CT values and underwent colposcopy with biopsy. HPV testing was performed using the Allplex HPV HR Detection assay, and diagnostic performance was evaluated using receiver operating characteristic analysis. Results: Among 677 hrHPV‐positive women, 286 met the eligibility criteria, with cervical intraepithelial neoplasia 2 or higher (CIN2+) detected in 56 (19.6%). HPV16, HPV52, and HPV58 were the most common genotypes in CIN2+ cases. CT values were significantly inversely correlated with lesion severity ( r = −0.13, P = 0.025). For non‐16/18 hrHPV infections, a CT cutoff value of <32.94 improved the area under the curve from 0.54 to 0.65, yielding a sensitivity and specificity of 89% and 41%, respectively. Conclusion: Cycle threshold values demonstrated modest discriminatory performance. Therefore, they should not be used as the sole biomarkers for triage; rather, they should be used as a supplementary tool to aid in clinical decision‐making. Further validation in larger prospective studies is warranted.
- Open Access
- 15 July 2025
- Published by Korean Society of Obstetrics and Gynecology in Obstetrics & Gynecology Science
- Vol. 68 (4) , 346-348
Bleeding control and posterior vaginal fornix approach for cesarean hysterectomy in placenta accreta spectrum
ObjectivePlacenta accreta spectrum (PAS) is a leading cause of massive obstetric hemorrhage, particularly when the placenta is removed or unintentionally disrupted during cesarean hysterectomy. In this video, we demonstrate an alternative surgical approach via the posterior vaginal fornix for performing cesarean hysterectomy in patients with PAS.MethodsA cesarean hysterectomy for a case of placenta percreta was performed using the posterior vaginal fornix approach. This technique focuses on avoiding bleeding due to placental disruption and preventing urinary bladder injury.ResultsWe summarize the steps of the procedure, including ligation of the vascular pedicles, entry into the retroperitoneal space to identify vital structures and control bleeding, dissection along avascular plane to delineate organ borders, and posterior culdotomy followed by en bloc uterine amputation to avoid urinary bladder injury and minimize blood loss.ConclusionThe posterior vaginal fornix approach for cesarean hysterectomy in patients with PAS is an effective technique for minimizing bleeding from the highly vascular placental area. Additionally, it offers the advantage of reducing the risk of unintentional urinary bladder injury, thereby improving surgical outcomes in these challenging cases.
- 15 July 2025
- Published by Korean Society of Obstetrics and Gynecology in Obstetrics & Gynecology Science
- Vol. 68 (4) , 346-348
Open AccessBleeding control and posterior vaginal fornix approach for cesarean hysterectomy in placenta accreta spectrum
ObjectivePlacenta accreta spectrum (PAS) is a leading cause of massive obstetric hemorrhage, particularly when the placenta is removed or unintentionally disrupted during cesarean hysterectomy. In this video, we demonstrate an alternative surgical approach via the posterior vaginal fornix for performing cesarean hysterectomy in patients with PAS.MethodsA cesarean hysterectomy for a case of placenta percreta was performed using the posterior vaginal fornix approach. This technique focuses on avoiding bleeding due to placental disruption and preventing urinary bladder injury.ResultsWe summarize the steps of the procedure, including ligation of the vascular pedicles, entry into the retroperitoneal space to identify vital structures and control bleeding, dissection along avascular plane to delineate organ borders, and posterior culdotomy followed by en bloc uterine amputation to avoid urinary bladder injury and minimize blood loss.ConclusionThe posterior vaginal fornix approach for cesarean hysterectomy in patients with PAS is an effective technique for minimizing bleeding from the highly vascular placental area. Additionally, it offers the advantage of reducing the risk of unintentional urinary bladder injury, thereby improving surgical outcomes in these challenging cases.
- Open Access
Novel Preoperative Carbohydrate Drinks Versus Commercial Syrup-Based Drinks on Gastric Emptying, Glycemic Responses, and Fasting Discomfort: A Pilot Randomized Crossover Trial
Background: Enhanced Recovery After Surgery (ERAS) guidelines recommend preoperative carbohydrate loading; however, local hospitals often use syrup concentrate sweet drinks rather than specialized carbohydrate formulations. We compared gastric emptying, glycemic response, and fasting discomfort of a novel carbohydrate drink versus syrup concentrate sweet drinks. Methods: In this pilot randomized, crossover trial at Prince of Songkla University Hospital, Thailand, 16 healthy volunteers received three interventions with a 1-week washout period: novel carbohydrate drink 400 mL (C400), novel carbohydrate drink 250 mL (C250), and syrup sweet drink 250 mL (SYR). The primary outcome was gastric antral cross-sectional area (CSA) measured using ultrasonography at baseline, 10, 60, 120, and 180 min post-ingestion. Secondary outcomes included glycemic response and visual analog scales for thirst and hunger. Results: All drinks showed comparable gastric CSA, peaking at 10 min (5.5–6.5 cm2, p < 0.01) and returning to baseline by 120 min. Novel carbohydrate drinks produced higher glucose peaks at 60 min (C400: 147.4 mg/dL [28.0]; C250: 148.7 mg/dL [21.7]) than SYR (123.1 mg/dL [22.4], p = 0.006) with sustained elevation through 120 min. All drinks similarly reduced thirst and mouth dryness scores at 60 min (p < 0.05), though hunger increased progressively after 120 min across all groups. Conclusions: Both 400 mL and 250 mL volumes of novel carbohydrate drinks demonstrated safe gastric emptying profiles comparable to syrup concentrate sweet drinks while providing more sustained glycemic responses.
Open AccessNovel Preoperative Carbohydrate Drinks Versus Commercial Syrup-Based Drinks on Gastric Emptying, Glycemic Responses, and Fasting Discomfort: A Pilot Randomized Crossover Trial
Background: Enhanced Recovery After Surgery (ERAS) guidelines recommend preoperative carbohydrate loading; however, local hospitals often use syrup concentrate sweet drinks rather than specialized carbohydrate formulations. We compared gastric emptying, glycemic response, and fasting discomfort of a novel carbohydrate drink versus syrup concentrate sweet drinks. Methods: In this pilot randomized, crossover trial at Prince of Songkla University Hospital, Thailand, 16 healthy volunteers received three interventions with a 1-week washout period: novel carbohydrate drink 400 mL (C400), novel carbohydrate drink 250 mL (C250), and syrup sweet drink 250 mL (SYR). The primary outcome was gastric antral cross-sectional area (CSA) measured using ultrasonography at baseline, 10, 60, 120, and 180 min post-ingestion. Secondary outcomes included glycemic response and visual analog scales for thirst and hunger. Results: All drinks showed comparable gastric CSA, peaking at 10 min (5.5–6.5 cm2, p < 0.01) and returning to baseline by 120 min. Novel carbohydrate drinks produced higher glucose peaks at 60 min (C400: 147.4 mg/dL [28.0]; C250: 148.7 mg/dL [21.7]) than SYR (123.1 mg/dL [22.4], p = 0.006) with sustained elevation through 120 min. All drinks similarly reduced thirst and mouth dryness scores at 60 min (p < 0.05), though hunger increased progressively after 120 min across all groups. Conclusions: Both 400 mL and 250 mL volumes of novel carbohydrate drinks demonstrated safe gastric emptying profiles comparable to syrup concentrate sweet drinks while providing more sustained glycemic responses.
- 8 January 2024
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 165 (2) , 813-822
Successful multidisciplinary team management of placenta accreta spectrum disorder: A referral center model in a middle‐income country
Objective: The aim of the study was to evaluate the outcomes of placenta accreta spectrum (PAS) disorder managed by a multidisciplinary care team (MCT) compared with a conventional care team (CCT) in a PAS referral center in Thailand.Methods: This retrospective single‐center cohort study analyzed PAS management outcomes in the PSU PAS Center between January 2010 and December 2022. The incidence of hemorrhage ≥3500 mL and the composite maternal and neonatal outcomes of PAS were compared before and after the introduction of an MCT in 2016.Results: Of 227 PAS cases, 219 (96.5%) had pathological confirmation. There were 52 (22.9%) cases of placenta accreta, 119 (52.4%) cases of placenta increta, and 56 (24.7%) cases of placenta percreta. The incidence of estimated blood loss (EBL) ≥3500 mL decreased from 61.8% to 34.3% (P < 0.001) after the establishment of the MCT. The median EBL decreased from 4000 (IQR: 2600,7250) mL to 2250 (1300, 4750) mL (P < 0.001). EBL reduction was statistically significant in the accreta and increta groups (P < 0.001). Red blood cell transfusions decreased from five (3, 9) to two (1, 6) units (P < 0.001) per patient. The length of maternal hospital stays and ICU admissions were statistically shorter when PAS was managed by an MCT (P < 0.001). The length of newborn hospital and ICU stays decreased significantly (P < 0.001).Conclusion: The incidence of massive postpartum hemorrhage and a composite of maternal and neonatal morbidities in pregnant women with PAS disorder improved significantly after the establishment of an MCT to manage PAS in a middle‐income country setting.
- 8 January 2024
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 165 (2) , 813-822
Successful multidisciplinary team management of placenta accreta spectrum disorder: A referral center model in a middle‐income country
Objective: The aim of the study was to evaluate the outcomes of placenta accreta spectrum (PAS) disorder managed by a multidisciplinary care team (MCT) compared with a conventional care team (CCT) in a PAS referral center in Thailand.Methods: This retrospective single‐center cohort study analyzed PAS management outcomes in the PSU PAS Center between January 2010 and December 2022. The incidence of hemorrhage ≥3500 mL and the composite maternal and neonatal outcomes of PAS were compared before and after the introduction of an MCT in 2016.Results: Of 227 PAS cases, 219 (96.5%) had pathological confirmation. There were 52 (22.9%) cases of placenta accreta, 119 (52.4%) cases of placenta increta, and 56 (24.7%) cases of placenta percreta. The incidence of estimated blood loss (EBL) ≥3500 mL decreased from 61.8% to 34.3% (P < 0.001) after the establishment of the MCT. The median EBL decreased from 4000 (IQR: 2600,7250) mL to 2250 (1300, 4750) mL (P < 0.001). EBL reduction was statistically significant in the accreta and increta groups (P < 0.001). Red blood cell transfusions decreased from five (3, 9) to two (1, 6) units (P < 0.001) per patient. The length of maternal hospital stays and ICU admissions were statistically shorter when PAS was managed by an MCT (P < 0.001). The length of newborn hospital and ICU stays decreased significantly (P < 0.001).Conclusion: The incidence of massive postpartum hemorrhage and a composite of maternal and neonatal morbidities in pregnant women with PAS disorder improved significantly after the establishment of an MCT to manage PAS in a middle‐income country setting.
- Open Access
- 1 December 2023
- Published by Chiang Mai University in Biomedical Sciences and Clinical Medicine
- Vol. 62 (4) , 181-192
Knowledge, Attitudes, Practices, and Acceptance of Gynecologic Cancer Patients Toward Covid-19 Vaccine in Thailand: A Multicenter Cross-sectional Study
OBJECTIVE To evaluate the knowledge, attitudes, practices (KAP), and acceptance of gynecologic cancer patients from the 4 regions of Thailand related to the COVID-19 vaccine. METHODS Gynecologic cancer patients from Chiang Mai University Hospital, Khon Kaen University Hospital, Khon Kaen Hospital, Prince of Songkhla University Hospital, and the National Cancer Institute (NCI) in Bangkok were surveyed using a WHO survey instrument. RESULTS Between February and September 2022, 1,263 patients partici-pated in this project of whom 1,084 (85.8%) had received the COVID-19 vaccine. The highest rate of vaccination was the NCI followed by Khon Kaen, Chiang Mai, and Songkhla. Of the participants, 28.2% were infected with COVID-19 and 12.9% of the infected participants were unvaccinated. Regarding KAP, the average scale level of overall participants reported ease in obtaining health literacy, a moderate probability of having severe COVID-19 infection, knowledge and adoption of proper appropriate behavior for the prevention of COVID infection, little stress regarding possible COVID-19 infection, and quite a lot of a significant level of trust in healthcare workers. Most participants generally agreed with the lifting of some regular rules to reduce the risk of infection and often many expressed a feeling of general well-being. The significantly different levels of rating scale by unvaccinated and vaccinated participants in the key areas were as follows: (Patients rated each of the areas investigated on a scale of 0 to 6, with 0 indicating lowest level of agreement/acceptance and 6 indicating the highest level) health ministry recommendations (3.92 vs. 4.16), ease of getting the COVID vaccine (3.6 vs. 3.9), “no need to receive the vaccine due to the disease being rare” (2.6 vs. 2.2), “stress made me not want to get vaccinated” (2.6 vs. 2.1), “if everyone is vaccinated, no need for me to vaccinate” (2.5 vs. 1.9), and the importance of COVID-19 vaccines (3.7 vs. 4.2). CONCLUSIONS Most gynecologic cancer patients from the 4 regions of Thailand had received the COVID-19 vaccine and exhibited good knowledge, attitudes, and practices related to this pandemic. KEYWORDS COVID-19-vaccine, gynecologic cancer patients, attitude, practice
- 1 December 2023
- Published by Chiang Mai University in Biomedical Sciences and Clinical Medicine
- Vol. 62 (4) , 181-192
Open AccessKnowledge, Attitudes, Practices, and Acceptance of Gynecologic Cancer Patients Toward Covid-19 Vaccine in Thailand: A Multicenter Cross-sectional Study
OBJECTIVE To evaluate the knowledge, attitudes, practices (KAP), and acceptance of gynecologic cancer patients from the 4 regions of Thailand related to the COVID-19 vaccine. METHODS Gynecologic cancer patients from Chiang Mai University Hospital, Khon Kaen University Hospital, Khon Kaen Hospital, Prince of Songkhla University Hospital, and the National Cancer Institute (NCI) in Bangkok were surveyed using a WHO survey instrument. RESULTS Between February and September 2022, 1,263 patients partici-pated in this project of whom 1,084 (85.8%) had received the COVID-19 vaccine. The highest rate of vaccination was the NCI followed by Khon Kaen, Chiang Mai, and Songkhla. Of the participants, 28.2% were infected with COVID-19 and 12.9% of the infected participants were unvaccinated. Regarding KAP, the average scale level of overall participants reported ease in obtaining health literacy, a moderate probability of having severe COVID-19 infection, knowledge and adoption of proper appropriate behavior for the prevention of COVID infection, little stress regarding possible COVID-19 infection, and quite a lot of a significant level of trust in healthcare workers. Most participants generally agreed with the lifting of some regular rules to reduce the risk of infection and often many expressed a feeling of general well-being. The significantly different levels of rating scale by unvaccinated and vaccinated participants in the key areas were as follows: (Patients rated each of the areas investigated on a scale of 0 to 6, with 0 indicating lowest level of agreement/acceptance and 6 indicating the highest level) health ministry recommendations (3.92 vs. 4.16), ease of getting the COVID vaccine (3.6 vs. 3.9), “no need to receive the vaccine due to the disease being rare” (2.6 vs. 2.2), “stress made me not want to get vaccinated” (2.6 vs. 2.1), “if everyone is vaccinated, no need for me to vaccinate” (2.5 vs. 1.9), and the importance of COVID-19 vaccines (3.7 vs. 4.2). CONCLUSIONS Most gynecologic cancer patients from the 4 regions of Thailand had received the COVID-19 vaccine and exhibited good knowledge, attitudes, and practices related to this pandemic. KEYWORDS COVID-19-vaccine, gynecologic cancer patients, attitude, practice
- Open Access
- 17 March 2023
- Published by Wiley in Case Reports in Obstetrics and Gynecology
- Vol. 2023, 1-7
Secondary Erythrocytosis Associated with Uterine Myoma Is Rare but Should Be of Concern
Myomatous erythrocytosis syndrome (MES) is a rare gynecological condition, defined by the presence of the clinical triad of erythrocytosis, uterine fibroids, and normalization of red blood cell counts after the surgical removal of uterine fibroids. Herein, we report the case of a woman, in the postmenopausal stage, with the clinical triad of MES. She had a history of erythrocytosis of unknown etiology and underwent phlebotomy for a year prior to visiting our hospital. Pre-operative hemoglobin (Hb) level, hematocrit (Hct) level, and red blood cell (RBC) count were 18.1g/dL, 56.1, and 6.52 million cells/μL, respectively. She underwent exploratory laparotomy, transabdominal hysterectomy, and bilateral salpingo-oophorectomy. The operative findings revealed a large uterine myoma, and the pathology result was compatible with uterine leiomyoma. All hematologic parameters returned to the normal range on post-operative day 1. Her hematologic parameters returned to normal values 4 weeks after surgery with a Hb level of 13.5g/dL, Hct level of 41.2, and RBC count of 4.92 million cells/μL. The exact pathophysiology of this condition remains unknown. However, surgical removal of uterine myoma is the mainstay of treatment. Despite the rarity of this condition, its diagnosis should be considered in patients presenting with erythrocytosis and uterine masses.
- 17 March 2023
- Published by Wiley in Case Reports in Obstetrics and Gynecology
- Vol. 2023, 1-7
Open AccessSecondary Erythrocytosis Associated with Uterine Myoma Is Rare but Should Be of Concern
Myomatous erythrocytosis syndrome (MES) is a rare gynecological condition, defined by the presence of the clinical triad of erythrocytosis, uterine fibroids, and normalization of red blood cell counts after the surgical removal of uterine fibroids. Herein, we report the case of a woman, in the postmenopausal stage, with the clinical triad of MES. She had a history of erythrocytosis of unknown etiology and underwent phlebotomy for a year prior to visiting our hospital. Pre-operative hemoglobin (Hb) level, hematocrit (Hct) level, and red blood cell (RBC) count were 18.1g/dL, 56.1, and 6.52 million cells/μL, respectively. She underwent exploratory laparotomy, transabdominal hysterectomy, and bilateral salpingo-oophorectomy. The operative findings revealed a large uterine myoma, and the pathology result was compatible with uterine leiomyoma. All hematologic parameters returned to the normal range on post-operative day 1. Her hematologic parameters returned to normal values 4 weeks after surgery with a Hb level of 13.5g/dL, Hct level of 41.2, and RBC count of 4.92 million cells/μL. The exact pathophysiology of this condition remains unknown. However, surgical removal of uterine myoma is the mainstay of treatment. Despite the rarity of this condition, its diagnosis should be considered in patients presenting with erythrocytosis and uterine masses.
- Open Access
- 15 March 2022
- Published by Korean Society of Obstetrics and Gynecology in Obstetrics & Gynecology Science
- Vol. 65 (2) , 188-196
Incidence and predictive factors for recurrent clear cell ovarian carcinoma: results from a single center in Thailand
ObjectiveWe aimed to study the incidence and predictive factors of recurrent clear cell ovarian carcinoma (CCC) and evaluate the oncological outcomes after recurrence.MethodsThis was a retrospective study of 134 CCC cases diagnosed between 2005 and 2020. Clinicopathological data and oncological outcomes were extracted and evaluated. Patients with co-malignancy, mixed pathological type, or incomplete data were excluded. Descriptive statistics, univariate and multivariable analyses, and Kaplan-Meier survival probability estimates were completed. A proportional hazards model was used to assess the association between the prognostic factors with progression-free survival (PFS), overall survival (OS), and post-recurrence survival.ResultsA total of 134 patients with CCC were enrolled. The incidence of recurrent CCC was 33.6% (45/134). The median PFS was 12.8 months (95% confidence interval [CI], 9.66-18.9) in the recurrence group and 3.3 months (95% CI, 1.15-4.4) in the refractory group. Residual tumor from surgical outcome, ascites cytology, and lymphovascular space invasion (LVSI) were independent prognostic factors for PFS. The significant variables were residual tumor (sub-optimal surgery vs. optimal surgery) (hazard ratio [HR], 2.68; 95% CI, 1.48-4.87; P=0.002), ascites cytology (positive vs. negative) (HR, 2.8; 95% CI, 1.58-4.98; P=0.002), and LVSI (positive vs. negative) (HR, 2.14; 95% CI, 1.18-3.86; P=0.04). The median postrecurrence survival was 13.96 months (95% CI, 10.61-26.2) in the recurrence group.ConclusionCCC has a high rate of recurrence. Sub-optimal surgery, positive ascites cytology, and LVSI indicated a worse prognosis for PFS. Optimal cytoreductive surgery is an important part of primary treatment to improve survival in patients with CCC.
- 15 March 2022
- Published by Korean Society of Obstetrics and Gynecology in Obstetrics & Gynecology Science
- Vol. 65 (2) , 188-196
Open AccessIncidence and predictive factors for recurrent clear cell ovarian carcinoma: results from a single center in Thailand
ObjectiveWe aimed to study the incidence and predictive factors of recurrent clear cell ovarian carcinoma (CCC) and evaluate the oncological outcomes after recurrence.MethodsThis was a retrospective study of 134 CCC cases diagnosed between 2005 and 2020. Clinicopathological data and oncological outcomes were extracted and evaluated. Patients with co-malignancy, mixed pathological type, or incomplete data were excluded. Descriptive statistics, univariate and multivariable analyses, and Kaplan-Meier survival probability estimates were completed. A proportional hazards model was used to assess the association between the prognostic factors with progression-free survival (PFS), overall survival (OS), and post-recurrence survival.ResultsA total of 134 patients with CCC were enrolled. The incidence of recurrent CCC was 33.6% (45/134). The median PFS was 12.8 months (95% confidence interval [CI], 9.66-18.9) in the recurrence group and 3.3 months (95% CI, 1.15-4.4) in the refractory group. Residual tumor from surgical outcome, ascites cytology, and lymphovascular space invasion (LVSI) were independent prognostic factors for PFS. The significant variables were residual tumor (sub-optimal surgery vs. optimal surgery) (hazard ratio [HR], 2.68; 95% CI, 1.48-4.87; P=0.002), ascites cytology (positive vs. negative) (HR, 2.8; 95% CI, 1.58-4.98; P=0.002), and LVSI (positive vs. negative) (HR, 2.14; 95% CI, 1.18-3.86; P=0.04). The median postrecurrence survival was 13.96 months (95% CI, 10.61-26.2) in the recurrence group.ConclusionCCC has a high rate of recurrence. Sub-optimal surgery, positive ascites cytology, and LVSI indicated a worse prognosis for PFS. Optimal cytoreductive surgery is an important part of primary treatment to improve survival in patients with CCC.
- Open Access
- 1 January 2018
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 29 (4) , e52
Quality of tissue from punch biopsy forceps vs. round loop electrode in colposcopically directed biopsy: a randomized controlled trial
Wetcho T, et al. J Gynecol Oncol. 2017 Dec;29:e52. https://doi.org/10.3802/jgo.2018.29.e52
- 1 January 2018
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 29 (4) , e52
Open AccessQuality of tissue from punch biopsy forceps vs. round loop electrode in colposcopically directed biopsy: a randomized controlled trial
Wetcho T, et al. J Gynecol Oncol. 2017 Dec;29:e52. https://doi.org/10.3802/jgo.2018.29.e52
- Open Access
- 13 July 2015
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 16 (12) , 5037-5041
Human Chorionic Gonadotropin (hCG) Regression Curve for Predicting Response to EMA/CO (Etoposide, Methotrexate, Actinomycin D, Cyclophosphamide and Vincristine) Regimen in Gestational Trophoblastic Neoplasia
An hCG regression curve has been used to predict the natural history and response to chemotherapy in gestational trophoblastic disease. We constructed hCG regression curves in high-risk gestational trophoblastic neoplasia (GTN) treated with EMA/CO and identified an optimal hCG level to detect EMA/CO resistance in GTN. Eighty-one women with GTN treated with EMA/CO were classified as primary high-risk GTN (n=65) and single agent-resistance GTN (n=16). The hCG levels prior to each course of chemotherapy were plotted in the 10th, 50th, and 90th percentiles to construct the hCG regression curves. Diagnostic performance was evaluated for an optimal cut-off value. The median hCG levels were 264,482 mIU/mL mIU/mL and 495.5 mIU/mL mIU/mL for primary high-risk GTN and single agent-resistance GTN, respectively. The 50th percentile of the hCG level in primary high-risk GTN and single agent-resistance turned to normal before the 4th and the 2nd course of chemotherapy, respectively. The 90th percentile of the hCG level in primary high-risk GTN and single agent-resistance turned to normal before the 9th and the 2nd course of chemotherapy, respectively. The hCG level of ≥118.6 mIU/mL mIU/mL at the 5thcourse of EMA/CO predicted the EMA/CO resistance in primary high-risk GTN patients with a sensitivity of 85.7% and a specificity of 100%. EMA/CO resistance in primary high-risk GTN can be predicted by using an hCG regression curve in combination with the cut-off value of 118.6 mIU/mL at the 5thcourse of chemotherapy.
- 13 July 2015
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 16 (12) , 5037-5041
Open AccessHuman Chorionic Gonadotropin (hCG) Regression Curve for Predicting Response to EMA/CO (Etoposide, Methotrexate, Actinomycin D, Cyclophosphamide and Vincristine) Regimen in Gestational Trophoblastic Neoplasia
An hCG regression curve has been used to predict the natural history and response to chemotherapy in gestational trophoblastic disease. We constructed hCG regression curves in high-risk gestational trophoblastic neoplasia (GTN) treated with EMA/CO and identified an optimal hCG level to detect EMA/CO resistance in GTN. Eighty-one women with GTN treated with EMA/CO were classified as primary high-risk GTN (n=65) and single agent-resistance GTN (n=16). The hCG levels prior to each course of chemotherapy were plotted in the 10th, 50th, and 90th percentiles to construct the hCG regression curves. Diagnostic performance was evaluated for an optimal cut-off value. The median hCG levels were 264,482 mIU/mL mIU/mL and 495.5 mIU/mL mIU/mL for primary high-risk GTN and single agent-resistance GTN, respectively. The 50th percentile of the hCG level in primary high-risk GTN and single agent-resistance turned to normal before the 4th and the 2nd course of chemotherapy, respectively. The 90th percentile of the hCG level in primary high-risk GTN and single agent-resistance turned to normal before the 9th and the 2nd course of chemotherapy, respectively. The hCG level of ≥118.6 mIU/mL mIU/mL at the 5thcourse of EMA/CO predicted the EMA/CO resistance in primary high-risk GTN patients with a sensitivity of 85.7% and a specificity of 100%. EMA/CO resistance in primary high-risk GTN can be predicted by using an hCG regression curve in combination with the cut-off value of 118.6 mIU/mL at the 5thcourse of chemotherapy.